483 Biocon Biologics India Jan 2009

483 Biocon Biologics India Jan 2009

Regina Brown FDA, Barbara Paul FDA$119.00 - Available Now

FDA investigators audited the Biocon Biologics India - Bengaluru, India facility and issued inspectional observations (via FDA 483) on 29 Jan 2009.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Jan 2009
  • Location: Bengaluru, India
  • FEI: 3003981475
Add To Cart